Entrez Id: |
7012 |
Gene Symbol: |
TERC |
TERC
|
|
telomerase RNA component
|
|
296
|
0.471 |
0.846 |
|
0.140 |
None
|
1.000 |
4
|
0
|
2004 |
2012 |
Entrez Id: |
406991 |
Gene Symbol: |
MIR21 |
MIR21
|
|
microRNA 21
|
|
726
|
0.363 |
0.846 |
|
0.020 |
None
|
1.000 |
2
|
0
|
2013 |
2019 |
KLRC4-KLRK1
|
P26718
|
KLRC4-KLRK1 readthrough
|
|
246
|
0.469 |
0.769 |
|
0.010 |
None
|
1.000 |
1
|
0
|
2020 |
2020 |
Entrez Id: |
2414 |
Gene Symbol: |
FRA7G |
FRA7G
|
|
fragile site, aphidicolin type, common, fra(7)(q31.2)
|
|
28
|
0.695 |
0.462 |
|
0.010 |
None
|
1.000 |
1
|
0
|
2009 |
2009 |
Entrez Id: |
407040 |
Gene Symbol: |
MIR34A |
MIR34A
|
|
microRNA 34a
|
|
428
|
0.421 |
0.846 |
|
0.010 |
None
|
1.000 |
1
|
0
|
2017 |
2017 |
Entrez Id: |
494337 |
Gene Symbol: |
MIR425 |
MIR425
|
|
microRNA 425
|
|
78
|
0.581 |
0.654 |
|
0.010 |
None
|
1.000 |
1
|
0
|
2017 |
2017 |
Entrez Id: |
6012 |
Gene Symbol: |
RIEG2 |
RIEG2
|
|
Rieger syndrome 2
|
|
38
|
0.674 |
0.462 |
|
0.010 |
None
|
1.000 |
1
|
0
|
2019 |
2019 |
Entrez Id: |
653108 |
Gene Symbol: |
CXADRP1 |
CXADRP1
|
|
CXADR pseudogene 1
|
|
272
|
0.463 |
0.846 |
|
0.010 |
None
|
1.000 |
1
|
0
|
2019 |
2019 |
Entrez Id: |
693159 |
Gene Symbol: |
MIR574 |
MIR574
|
|
microRNA 574
|
|
71
|
0.599 |
0.577 |
|
0.010 |
None
|
1.000 |
1
|
0
|
2017 |
2017 |
Entrez Id: |
8101 |
Gene Symbol: |
CLLS2 |
CLLS2
|
|
Disrupted in B-cell neoplasia
|
|
34
|
0.678 |
0.346 |
|
0.010 |
None
|
1.000 |
1
|
0
|
2009 |
2009 |
Entrez Id: |
2175 |
Gene Symbol: |
FANCA |
FANCA
|
O15360
|
FA complementation group A
|
|
211
|
0.505 |
0.731 |
1.6E-68 |
0.420 |
strong
|
1.000 |
4
|
0
|
1996 |
2019 |
Entrez Id: |
54790 |
Gene Symbol: |
TET2 |
TET2
|
Q6N021
|
tet methylcytosine dioxygenase 2
|
|
362
|
0.458 |
0.808 |
4.3E-54 |
0.100 |
None
|
|
0
|
0
|
|
|
Entrez Id: |
472 |
Gene Symbol: |
ATM |
ATM
|
Q13315
|
ATM serine/threonine kinase
|
Kinase
|
684
|
0.374 |
0.885 |
5.6E-47 |
0.020 |
None
|
1.000 |
2
|
0
|
2002 |
2009 |
Entrez Id: |
55215 |
Gene Symbol: |
FANCI |
FANCI
|
Q9NVI1
|
FA complementation group I
|
|
147
|
0.543 |
0.731 |
8.9E-37 |
0.300 |
strong
|
1.000 |
1
|
0
|
2017 |
2017 |
Entrez Id: |
6687 |
Gene Symbol: |
SPG7 |
SPG7
|
Q9UQ90
|
SPG7 matrix AAA peptidase subunit, paraplegin
|
Enzyme
|
419
|
0.436 |
0.885 |
2.0E-36 |
0.010 |
None
|
1.000 |
1
|
0
|
2019 |
2019 |
Entrez Id: |
9401 |
Gene Symbol: |
RECQL4 |
RECQL4
|
O94761
|
RecQ like helicase 4
|
Enzyme
|
249
|
0.496 |
0.808 |
3.3E-35 |
0.020 |
None
|
1.000 |
2
|
0
|
2014 |
2019 |
Entrez Id: |
7486 |
Gene Symbol: |
WRN |
WRN
|
Q14191
|
WRN RecQ like helicase
|
Enzyme
|
172
|
0.524 |
0.808 |
2.6E-34 |
0.010 |
None
|
1.000 |
1
|
0
|
2013 |
2013 |
Entrez Id: |
54809 |
Gene Symbol: |
SAMD9 |
SAMD9
|
Q5K651
|
sterile alpha motif domain containing 9
|
|
90
|
0.606 |
0.808 |
1.1E-33 |
0.020 |
None
|
1.000 |
2
|
0
|
2017 |
2019 |
Entrez Id: |
2177 |
Gene Symbol: |
FANCD2 |
FANCD2
|
Q9BXW9
|
FA complementation group D2
|
|
272
|
0.479 |
0.885 |
1.1E-30 |
0.430 |
strong
|
0.750 |
4
|
0
|
2015 |
2019 |
Entrez Id: |
672 |
Gene Symbol: |
BRCA1 |
BRCA1
|
P38398
|
BRCA1 DNA repair associated
|
Enzyme
|
747
|
0.367 |
0.923 |
9.2E-29 |
0.030 |
None
|
1.000 |
3
|
0
|
2016 |
2019 |
Entrez Id: |
3563 |
Gene Symbol: |
IL3RA |
IL3RA
|
P26951
|
interleukin 3 receptor subunit alpha
|
Signaling
|
95
|
0.560 |
0.769 |
3.0E-27 |
0.010 |
None
|
< 0.001 |
1
|
0
|
2016 |
2016 |
Entrez Id: |
675 |
Gene Symbol: |
BRCA2 |
BRCA2
|
P51587
|
BRCA2 DNA repair associated
|
Nucleic acid binding
|
656
|
0.379 |
0.846 |
2.4E-25 |
0.310 |
strong
|
1.000 |
2
|
0
|
2017 |
2018 |
Entrez Id: |
55120 |
Gene Symbol: |
FANCL |
FANCL
|
Q9NW38
|
FA complementation group L
|
Enzyme
|
137
|
0.551 |
0.731 |
5.9E-23 |
0.300 |
strong
|
1.000 |
1
|
0
|
2017 |
2017 |
Entrez Id: |
6580 |
Gene Symbol: |
SLC22A1 |
SLC22A1
|
O15245
|
solute carrier family 22 member 1
|
Transporter
|
119
|
0.556 |
0.731 |
1.5E-22 |
0.010 |
None
|
1.000 |
1
|
0
|
2019 |
2019 |
Entrez Id: |
84464 |
Gene Symbol: |
SLX4 |
SLX4
|
Q8IY92
|
SLX4 structure-specific endonuclease subunit
|
|
123
|
0.565 |
0.731 |
1.6E-22 |
0.400 |
strong
|
1.000 |
1
|
0
|
2017 |
2017 |